Brief: Precipio Granted 180-Day Extension From Nasdaq To Regain Compliance
27/04/2023 22:55
Precipio Inc PRPO.O :
* PRECIPIO GRANTED 180-DAY EXTENSION FROM NASDAQ TO REGAIN
COMPLIANCE
Source text for Eikon: ID:nGNX4NyR7K
Further company coverage: PRPO.O
Recent news on Precipio
See all newsCancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive
Precipio Q1 revenue rises on higher pathology sales
Blood cancer diagnostics firm Precipio's prelim Q4 revenue rises 23%
Brief: Precipio Identifies Unauthorized Access To Isolated Storage No Operational Impact
Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers